{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:48:34Z","timestamp":1757699314616},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.bbrc.2003.12.105","type":"journal-article","created":{"date-parts":[[2004,1,6]],"date-time":"2004-01-06T10:48:13Z","timestamp":1073386093000},"page":"403-408","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Angiotensin II type 1 receptor blockade attenuates renal fibrogenesis in an immune-mediated nephritic kidney through counter-activation of angiotensin II type 2 receptor"],"prefix":"10.1016","volume":"314","author":[{"given":"Hirokazu","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Kikuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Ban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2003.12.105_BIB1","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1046\/j.1523-1755.2000.00031.x","article-title":"Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists","volume":"57","author":"Taal","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB2","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1681\/ASN.V7102025","article-title":"Angiotensin in progressive renal diseases: theory and practice","volume":"7","author":"Matsusaka","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041552-200105000-00005","article-title":"Proinflammatory actions of angiotensins","volume":"10","author":"Ruiz-Ortega","year":"2001","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB4","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(98)04433-X","article-title":"Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial: Gruppo Italiano di Studi Epidemiologici in Nefrologia: Ramipril efficacy in nephropathy","volume":"352","author":"Ruggenenti","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2003.12.105_BIB5","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJM199604113341502","article-title":"Effect of angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency: The angiotensin-converting-enzyme inhibition in progressive renal insufficiency study group","volume":"334","author":"Maschio","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB6","first-page":"S2","article-title":"Molecular biology and signaling of angiotensin receptors: an overview","volume":"10","author":"Inagami","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1172\/JCI2454","article-title":"Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice","volume":"103","author":"Hisada","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(99)00276-9","article-title":"Angiotensin II type I receptor antagonist suppresses proteinuria and glomerular lesions in experimental nephritis","volume":"374","author":"Nagamatsu","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB9","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0002-9440(10)63036-2","article-title":"Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice","volume":"159","author":"Suzuki","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB10","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1172\/JCI115949","article-title":"Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass","volume":"90","author":"Lafayette","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB11","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/ki.1995.183","article-title":"Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction","volume":"47","author":"Ishidoya","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1681\/ASN.V122317","article-title":"Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice","volume":"12","author":"Satoh","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1681\/ASN.V4140","article-title":"Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes","volume":"4","author":"Remuzzi","year":"1993","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB14","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"RENAAL study investigators, effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(03)12229-5","article-title":"Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease: a randomised controlled trial","volume":"361","author":"Nakao","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2003.12.105_BIB16","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/01.RES.83.12.1182","article-title":"Pathophysiological role of antiogensin II type 2 receptor in cardiovascular and renal diseases","volume":"83","author":"Matsubara","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-0115(01)00246-4","article-title":"Angiotensin and its AT2 receptor: new insights into an old system","volume":"99","author":"Stoll","year":"2001","journal-title":"Reg. Pept."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB18","first-page":"F39","article-title":"Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis","volume":"276","author":"Morrissey","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1523-1755.1998.00893.x","article-title":"Accelerated fibrosis and collagen deposition develop in the real interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction","volume":"53","author":"Ma","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB20","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/01.ASN.0000019409.17099.33","article-title":"Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury","volume":"13","author":"Cao","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000174082","article-title":"Lack of a beneficial effect of PD123319, an AT2-angiotensin receptor antagonist, on the course of ablation nephropathy in the rat","volume":"19","author":"Cervenka","year":"1996","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0002-9440(10)64898-5","article-title":"Interstitial fibroblast-like cells express renin\u2013angiotensin system components in a fibrosing murine kidney","volume":"160","author":"Okada","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s004670000461","article-title":"Molecular basis of renal fibrosis","volume":"15","author":"Eddy","year":"2000","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB24","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM199811123392007","article-title":"Pathophysiology of progressive nephropathies","volume":"390","author":"Remuzzi","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.HYP.33.2.613","article-title":"Recent progress in angiotensin II type 2 receptor research in the cardiovascular system","volume":"33","author":"Horiuchi","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2003.12.105_BIB26","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1172\/JCI119615","article-title":"Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells","volume":"100","author":"Wolf","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB27","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1046\/j.1523-1755.2000.00427.x","article-title":"Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis","volume":"58","author":"Cao","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB28","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/labinvest.3780338","article-title":"An essential role of angiotensin II receptor type 1a in recipient kidney, not in transplanted peripheral blood leukocytes, in progressive immune-mediated renal injury","volume":"81","author":"Hisada","year":"2001","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB29","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1172\/JCI112528","article-title":"Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat","volume":"77","author":"Anderson","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2003.12.105_BIB30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/hy0202.103821","article-title":"Regulation of intrarenal angiotensin II in hypertension","volume":"39","author":"Navar","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2003.12.105_BIB31","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1172\/JCI119829","article-title":"Possible role of P450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole","volume":"100","author":"Arima","year":"1997","journal-title":"J. Clin. Invest."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X03027189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X03027189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T14:55:55Z","timestamp":1709564155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X03027189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0006291X03027189"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2003.12.105","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin II type 1 receptor blockade attenuates renal fibrogenesis in an immune-mediated nephritic kidney through counter-activation of angiotensin II type 2 receptor","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2003.12.105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}